Ke Ji

机构：Harbin Medical University, Henan University of Traditional Chinese Medicine, The University of Texas at Dallas, Peking University, Peking University Cancer Hospital, Zhengzhou Central Hospital, Ministry of Education · ORCID：0000-0002-0085-9646

发表论文 72 篇 · 总被引 1559 次 · h-index 21

代表论文

• Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial (2023 · The Lancet Oncology · 被引 206)
• Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial (2024 · Nature Medicine · 被引 45)
• Transcriptome and Anatomical Comparisons Reveal the Effects of Methyl Jasmonate on the Seed Development of Camellia oleifera (2023 · Journal of Agricultural and Food Chemistry · 被引 21)
• Rational Design of the β‐Bulge Gate in a Green Fluorescent Protein Accelerates the Kinetics of Sulfate Sensing** (2023 · Angewandte Chemie International Edition · 被引 13)
• Methionine played a positive role in improving the intestinal digestion capacity, anti-inflammatory reaction and oxidation resistance of grass carp, Ctenopharyngodon idella, fry (2022 · Fish & Shellfish Immunology · 被引 13)
• Integrative analysis of the metabolome and transcriptome provides novel insights into the mechanisms of flavonoid biosynthesis in Camellia lanceoleosa (2022 · Scientia Horticulturae · 被引 11)